Biocon Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: BIOCON BSE: 532523

₹370.30

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #13 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Biocon Limited (this stock)	60,348	597.3	1.0%	6.9%	0.14%	43	44	28

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹61,406 Cr

EV / EBITDA

164.0x

EV / Sales

25.23x

Market cap / Sales

24.80x

Earnings yield

0.17%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 689 Cr, up 15.2% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 52 Cr, down 728.9% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	624	70	52	₹0.3200
March 31, 2026	605	57	51	₹0.3200
Dec. 31, 2025	621	-84	-76	₹-0.5700
Sept. 30, 2025	583	86	71	₹0.5500
June 30, 2025	537	-8	-8	₹-0.0700
March 31, 2025	644	35	21	₹0.1800
Dec. 31, 2024	563	604	584	₹4.8800
Sept. 30, 2024	525	21	3	₹0.0300
June 30, 2024	511	1	1	₹0.0100
March 31, 2024	533	22	14	₹0.1200
Dec. 31, 2023	563	33	24	₹0.2000
Sept. 30, 2023	519	46	35	₹0.2900
June 30, 2023	513	50	47	₹0.3900

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	689	654	696	717	598	706	627	599	552	572	611	588	549
Operating revenue	624	605	621	583	537	644	563	525	511	533	563	519	513
Other income	65	50	75	134	61	63	64	74	42	39	48	70	36
Operating expenses	564	525	548	530	516	582	532	488	466	480	492	452	441
Operating profit	61	79	73	53	21	62	31	38	45	52	71	67	72
Operating profit margin	9.7%	13.1%	11.8%	9.1%	3.8%	9.6%	5.6%	7.2%	8.8%	9.8%	12.7%	13.0%	14.0%
Depreciation	38	36	34	34	33	33	34	30	30	30	31	31	30
Interest	17	17	2	67	56	57	65	60	55	40	56	55	48
Exceptional items, gain / (loss)	—	-19	-196	—	—	—	608	—	—	—	—	-5	20
Profit before tax	70	57	-84	86	-8	35	604	21	1	22	33	46	50
Tax	18	6	-8	15	1	14	20	18	0	8	9	11	3
Net profit	52	51	—	71	-8	21	584	3	1	14	24	35	47
EPS	0.32	0.32	-0.57	0.55	-0.07	0.18	4.88	0.03	0.01	0.12	0.20	0.29	0.39
Net profit (TTM)	—	—	—	668	600	609	602	42	74	119	1,916	1,927	2,880
EPS (TTM)	0.62	0.23	0.09	5.54	5.02	5.10	5.04	0.36	0.62	1.00	16.05	16.14	24.13

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	2,346	51	37
March 31, 2025	2,243	661	609
March 31, 2024	2,127	150	119
March 31, 2023	1,993	2,971	2,848

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	5.6%	4.1%	2,666^†	2,485^†	2,320^†	2,264^†	1,925^†	2,181^†	2,192^†	3,030^†	2,566^†	2,711^†
Operating revenue	5.6%	3.0%	2,346	2,243	2,127	1,993	1,738^†	2,028^†	1,988^†	2,885^†	2,426^†	2,609^†
Other income	—	—	320^†	242^†	193^†	271^†	187^†	153^†	204^†	146^†	140^†	102^†
Operating expenses	—	—	2,120^†	2,067^†	1,865^†	—	—	1,719^†	1,705^†	—	2,123^†	—
Operating profit	—	-6.1%	226^†	176^†	263^†	—	—	310^†	284^†	—	303^†	—
Operating profit margin	—	—	9.6%^†	7.8%^†	12.3%^†	—	—	15.3%^†	14.3%^†	—	12.5%^†	—
Depreciation	—	—	137^†	128^†	121^†	117^†	108^†	104^†	98^†	147^†	136^†	—
Interest	—	—	142^†	237^†	199^†	—	—	0^†	1^†	—	1^†	4^†
Exceptional items, gain / (loss)	—	—	-215^†	608^†	14^†	2,863^†	0^†	0^†	160^†	199^†	0^†	0^†
Profit before tax	-74.2%	-32.3%	51	661	150	2,971	140^†	359^†	548^†	552^†	306^†	536^†
Tax	—	—	14^†	52^†	31^†	123^†	54^†	78^†	112^†	59^†	67^†	17^†
Net profit	-76.5%	-33.2%	37	609	119	2,848	86^†	280^†	—	493^†	238^†	519^†
EPS	-78.7%	-37.3%	0.23^†	5.10^†	1.00^†	23.86^†	0.71^†	2.37^†	3.70^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	9.6%^†	7.8%^†	12.3%^†	—	—	15.3%^†	14.3%^†	—	12.5%^†	—
EBIT margin	8.2%^†	40.0%^†	16.4%^†	—	—	17.7%^†	27.6%^†	—	12.7%^†	20.7%^†
PBT margin	2.2%	29.5%	7.1%	149.1%	8.0%^†	17.7%^†	27.6%^†	19.1%^†	12.6%^†	20.6%^†
Net margin	1.6%	27.2%	5.6%	142.9%	5.0%^†	13.8%^†	—	17.1%^†	9.8%^†	19.9%^†
Interest coverage	1.36x^†	3.79x^†	1.76x^†	—	—	898.00x^†	457.83x^†	—	219.43x^†	142.11x^†
Dividend payout	217.4%^†	9.8%^†	150.0%^†	2.1%^†	0.0%^†	0.0%^†	13.5%^†	—	—	—
Earnings retention	-117.4%^†	90.2%^†	-50.0%^†	97.9%^†	100.0%^†	100.0%^†	86.5%^†	—	—	—
Current ratio	1.16x	1.25x	—	—	—	—	—	—	—	—
Quick ratio	0.72x	0.77x	—	—	—	—	—	—	—	—
Debt to equity	0.04x	0.25x	—	—	—	—	—	—	—	—
Return on equity	0.1%	5.3%	—	—	—	—	—	—	—	—
Return on assets	0.1%	3.9%	—	—	—	—	—	—	—	—
Return on capital employed	0.7%^†	6.5%^†	—	—	—	—	—	—	—	—
Asset turnover	0.08x	0.14x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	-180	-6,582	6,602	283	-463
March 31, 2025	621	-989	495	317	304
March 31, 2024	-123	-296	344	302	-425
March 31, 2023	219	-1,178	1,039	262	-43
March 31, 2022	48	-306	112	239	-192

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	29,271	27,080	26,269	1,057	94	2,288	1,965	91	1,281	875
March 31, 2025	15,621	11,524	10,924	620	2,252	2,170	1,737	250	1,004	836
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.